Topic: PFA

“Software excellence” is a priority for Medtronic’s electrophysiology unit and is “central to the integrated […]

Adagio Medical (Nasdaq:ADGM) today announced the successful treatment of the first patient with its next-generation vCLAS […]

Adagio Medical (Nasdaq:ADGM) announced today that it submitted its premarket approval (PMA) application to the FDA […]

Atraverse was set up by Steven Mickelsen, Eric Sauter and John Slump. Mickelsen and Slump […]

Field Medical announced today that it named Dr. Mark A. Turco as CEO, effective immediately. Turco […]

Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in […]

Field Medical announced the presentation of clinical data from the first-in-human study of its FieldForce pulsed […]

Abbott(NYSE: ABT)+ today announced new clinical data supporting its minimally invasive therapies for treating AFib. Results […]

MARLBOROUGH, Mass.–(BUSINESS WIRE)–CardioFocus, Inc., a medical device company dedicated to advancing pulsed field ablation (PFA) […]

Dive Brief: Dive Insight: Medtronic’s portfolio of PFA catheters already includes Sphere-9 and PulseSelect. Sphere-9 improved […]

Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study […]

Stereotaxis (NYSE:STXS) announced today that it partnered with CardioFocus to advance robotic pulsed field ablation (PFA) technology. The […]

In recent years, the presence of per- and poly-fluoroalkyl substances (PFAS), commonly known as “forever […]

Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system […]

Field Medical announced that it closed a Series A financing round worth $40 million to support […]

Boston Scientific(NYSE: BSX)+ will face more benign competition than previously feared when it comes to pulsed […]

Boston Scientific(NYSE: BSX)+ continues to expand the reach of its Farapulse pulsed field ablation system for […]

Pulse Biosciences (Nasdaq:PLSE) today announced the first completed cases in a first-in-human feasibility study of its […]

Adagio Medical announced that it completed its previously announced business combination with Arya Sciences Acquisition Corp […]

Medtronic PulseSelect became the first pulsed field ablation (PFA) system to win FDA approval for […]

Volta Medical announced today that it entered into a joint development agreement with GE HealthCare (Nasdaq: GEHC)+. The […]

Pulse Biosciences (Nasdaq:PLSE) announced today that the FDA granted breakthrough device designation for its pulsed field […]

Boston Scientific (NYSE: BSX) has gained access to another huge market for its Farapulse pulsed field […]

Kardium today announced positive one-year outcomes from the first-in-human trial of its Globe pulsed field ablation […]

Medtronic Cardiac Ablation Solutions VP of Research and Business Development Tim Laske discusses the Sphere-9 […]

Johnson & Johnson MedTech’s Biosense Webster division presented new clinical data backing up its pulsed […]

Volta Medical today announced positive results from a study of its AI decision support system for […]

Boston Scientific(NYSE: BSX)+ today shared new data looking at the impact of post-ablation atrial arrhythmia (AA) […]

Medtronic(NYSE: MDT)+ today announced data demonstrating the safety and efficacy of its Affera mapping and ablation […]

Medtronic(NYSE: MDT)+ today announced its Symplicity Spyral renal denervation system won National Medical Products Administration (NMPA) […]

The investigational Medtronic Sphere-360 pulsed field ablation and mapping catheter uses nitinol for a feature […]

Johnson & Johnson’s Biosense Webster unit today announced positive three-month follow-up results from its SmartfIRE clinical trial. […]

J&J has received clearances to sell Varipulse in the European Union and Japan this year. The next step is […]

Pulse Biosciences (Nasdaq:PLSE) announced that its board of directors approved plans to initiate a rights offering […]